KennethBergerMD

Pulmonology • New Rochelle, NY

Asthma & COPD, Critical Care Medicine, Occupational & Environmental Lung Disease, Sleep Medicine

Physician

Join to view full profile

Dr. Berger is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Berger's full profile

Already have an account?

Office
43 Stony Gate Oval
Room M-15
New Rochelle, NY 10804
Phone+1 646-285-5154

Education & Training

NYU Grossman School of MedicineFellowship, Pulmonary Disease and Critical Care Medicine, 1992 - 1995
Montefiore Medical Center/Albert Einstein College of Medicine (Moses and Weiler Campuses)Residency, Internal Medicine, 1989 - 1992
Boston University School of MedicineClass of 1989

Certifications & Licensure

NY State Medical License 1991 - 2026
FL State Medical License 2013 - 2015

Publications & Presentations

PubMed

Changes in forced vital capacity over ≤ 13 years among patients with late-onset Pompe disease treated with alglucosidase alfa: new modeling of real-world data from the...
Kenneth I Berger, Yin-Hsiu Chien, Alberto Dubrovsky, Priya S Kishnani, Juan C Llerena Jr
Journal of Neurology. 2024-08-01
3 citations
Effect of avalglucosidase alfa on disease-specific and general patient-reported outcomes in treatment-naïve adults with late-onset Pompe disease compared with alglucos...
Antonio Toscano, Laurence Pollissard, Jérôme Msihid, Nadine van der Beek, Priya S Kishnani
Molecular Genetics and Metabolism. 2024-02-01
Applying the win ratio method in clinical trials of orphan drugs: an analysis of data from the COMET trial of avalglucosidase alfa in patients with late-onset Pompe di...
Matthias Boentert, Kenneth I Berger, Jordi Díaz-Manera, Mazen M Dimachkie, Alaa Hamed
Orphanet Journal of Rare Diseases. 2024-01-12